Stephen Feider Biography and Net Worth

CFO of Beta Bionics

In his role as CFO, Stephen is responsible for the finance, investor relations, human resources, customer service and IT organizations. His experience as a leader in the diabetes medical device industry began at Companion Medical, where the InPen system was first developed and launched to the US market. Medtronic acquired Companion Medical in 2020 and Stephen continued his career at Medtronic Diabetes. Prior to Companion Medical, Stephen worked as a CPA at PwC and Corporate Controller at Marathon Health. Stephen holds a Bachelors and Masters in Accountancy from Butler University.

What is Stephen Feider's net worth?: The estimated net worth of Stephen Feider is at least $2.22 million as of June 26th, 2026. Feider owns 165,931 shares of Beta Bionics stock worth more than $2,215,179 as of August 4th. This net worth approximation does not reflect any other assets that Feider may own. Learn More about Stephen Feider's net worth.
How do I contact Stephen Feider?: The corporate mailing address for Feider and other Beta Bionics executives is 11 HUGHES, IRVINE, CA, 92618. Beta Bionics can also be reached via phone at (949) 427-7785 and via email at [email protected]. Learn More on Stephen Feider's contact information.
Has Stephen Feider been buying or selling shares of Beta Bionics?: Stephen Feider has not been actively trading shares of Beta Bionics over the course of the past ninety days. Most recently, Stephen Feider sold 4,896 shares of the business's stock in a transaction on Monday, June 29th. The shares were sold at an average price of $17.03, for a transaction totalling $83,378.88. Following the completion of the sale, the chief financial officer now directly owns 165,931 shares of the company's stock, valued at $2,825,804.93. Learn More on Stephen Feider's trading history.
Who are Beta Bionics' active insiders?: Beta Bionics' insider roster includes Stephen Feider (CFO), Mark Hopman (Insider), Christy Jones (Director), Mike Mensinger (Insider), and Steven Russell (Insider). Learn More on Beta Bionics' active insiders.
Are insiders buying or selling shares of Beta Bionics?: In the last twelve months, insiders at the sold shares 40 times. They sold a total of 153,201 shares worth more than $3,081,206.69. The most recent insider tranaction occured on June, 29th when CFO Stephen Feider sold 4,896 shares worth more than $83,378.88. Insiders at Beta Bionics own 5.3% of the company. Learn More about insider trades at Beta Bionics.
Information on this page was last updated on 6/29/2026.

Stephen Feider Insider Trading History at Beta Bionics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/29/2026	Sell	4,896	$17.03	$83,378.88	165,931
6/26/2026	Sell	5,104	$17.05	$87,023.20	165,931
6/2/2026	Sell	6,676	$12.61	$84,184.36	166,053
3/2/2026	Sell	1,428	$12.36	$17,650.08	172,729
1/2/2026	Sell	20,000	$29.53	$590,600.00	42,614
12/2/2025	Sell	1,427	$29.34	$41,868.18	42,614
10/3/2025	Sell	4,982	$21.69	$108,059.58	44,041
10/1/2025	Sell	15,018	$20.76	$311,773.68	44,041
9/5/2025	Sell	100	$21.00	$2,100.00	44,041
9/2/2025	Sell	1,462	$18.86	$27,573.32	44,041
8/22/2025	Sell	4,413	$17.01	$75,065.13	45,503
8/19/2025	Sell	5,587	$17.03	$95,146.61	45,503
6/2/2025	Sell	1,497	$17.89	$26,781.33	45,503

Stephen Feider Buying and Selling Activity at Beta Bionics

Beta Bionics Company Overview

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Today's Range

Now: $14.03

$13.35

$14.46

50 Day Range

MA: $15.02

$11.63

$17.82

2 Week Range

Now: $14.03

$8.80

$32.71

Volume

927,900 shs

Average Volume

1,151,311 shs

Market Capitalization

$631.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.13